Product Profiles

Article

A round-up of the latest ophthalmic products

Diagnostic tool for corneal aberrations

AMO has recently received the CE Mark for the iDesign Advanced WaveScan Studio Aberrometer.

The diagnostic tool can be used to map and analyse corneal aberrations for wavefront-guided LASIK procedures. iDesign measures individual blueprints of the eyes, maps imperfections and creates a treatment plan.

For more information please visit http://www.abbottmedicaloptics.com/

Posterior segment instruments

Geuder has extended its posterior segment product collection Uno Colorline.

The instruments are now available in 20, 23 and 25 gauge ranges. New additions to the Uno Colorline range include one-use vitrectomy scissors for precise and hygienic cuts and a trocar chandelier set for high illumination.

For more information please visit http://www.geuder.de

Ocular surface interferometer

The LipiView, from TearScience, is an ocular surface interferometer used to capture, manipulate, analyse and store detailed digital images of the tear film for the assessment of dry eye in the lipid layer.

LipiView can be used in conjunction with dry eye symptom questionnaires and a Meibomian gland evaluation for overall dry eye assessments.

For further details please visit http://www.tearscience.com/

Femtosecond platform

Ziemer Ophthalmic Systems has launched the Femto LDV Z Model Z6. The femtosecond platform can be used for treating a wide range of applications in ocular surgery including: corneal surgeries, Z-LASIK, tunnels for intracorneal rings, intrastromal pockets for corneal inlays, lamellar (DSAEK and (DALK) and perforating keratoplasties.

For further information please visit http://www.femtoldv.com/

IOL for cataract patients

Oculentis has introduced the LENTIS Comfort Intraocular Lens for cataract patients who don't want a standard monofocal lens.

LENTIS will enable the patient to regain the best possible far vision, along with intermediate distance vision. Some patients may become spectacleindependent as a result of the lens.

Please visit this website for further information http://www.ocululentis.com/

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.